NCT07017127 (REMeDI2ME) is a NA clinical trial of Mediterranean diet in Diabetes Mellitus Type 2, sponsored by University of Split, School of Medicine.

Who is sponsoring NCT07017127?

NCT07017127 is sponsored by University of Split, School of Medicine.

What drugs are being tested in NCT07017127?

Interventions in NCT07017127: Mediterranean diet, Physical activity intervention, Psychological intervention.

What condition does NCT07017127 study?

NCT07017127 studies Diabetes Mellitus Type 2, Obese Diabetics.

Is NCT07017127 still recruiting?

NCT07017127 is currently recruiting now. Last updated 12 June 2025.

Last reviewed 2025-06-12 · How we verify

NCT07017127: REMeDI2ME

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Remission of Type 2 Diabetes With Lifestyle Intervention

Recruiting now NA Last updated 12 June 2025

What this trial tests

NA trial testing Mediterranean diet in Diabetes Mellitus Type 2 in 120 participants. Currently enrolling.

Timeline

1 May 2025

Primary endpoint
1 June 2027

17 December 2027

Quick facts

Lead sponsor	University of Split, School of Medicine
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	120
Start date	1 May 2025
Primary completion	1 June 2027
Estimated completion	17 December 2027
Sites	1 location across Croatia

Drugs / interventions tested

Mediterranean diet
Physical activity intervention
Psychological intervention

Conditions studied

Diabetes Mellitus Type 2 — all drugs for Diabetes Mellitus Type 2 →
Obese Diabetics — all drugs for Obese Diabetics →

Sponsor

University of Split, School of Medicine

Who can join

Adults 20 to 69, any sex, with Diabetes Mellitus Type 2 or Obese Diabetics. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to achieve diabetes type 2 (DM2) remission using intensive lifestyle intervention. The main questions it aims to answer are: * Does intensive lifestyle intervention (including Mediterranean diet with a caloric deficit, daily physical activity, increase in stress resilience and group support) lead to DM2 remission (HbA1c\<6.5%, without medications) * Can intensive lifestyle intervention (including Mediterranean diet with a caloric deficit, daily physical activity, increase in stress resilience and group support) result to weight loss of \>15 kg * Does intensive lifestyle intervention result in any side effects (secondary outcome) Researchers will compare intensive lifestyle intervention to the usual clinical care (control group). Participants in the experimental group will: * eat Mediterranean diet with a caloric deficit * perform daily physical activity * increase their stress resilience with psychosocial support of the group * enroll weekly in individual and group counseling and workshops for 6 months, following with 1.5 years of follow-up

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Mediterranean diet

Trials testing the same drug.

NCT07385716 — Evaluation of the Effect of Time-Restricted Feeding and Mediterranean Diet Model in Women With Polycystic Ovary Syndrome · NA · recruiting
NCT07055620 — Effects of Different Dietary Models on Eating Behavior and Obesity Management in Overweight and Obese Individuals · NA · completed
NCT06774079 — Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients · Phase 4 · recruiting
NCT06765369 — How the Mediterranean Diet Affects You: Predicting Responses Based on Your Microbiome · NA · not yet recruiting
NCT06634316 — Sarcopenia in Patients With Heart Failure · NA · active not recruiting

Other recruiting trials for Diabetes Mellitus Type 2

Currently open trials in the same condition.

NCT07011147 — Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery · NA · recruiting
NCT07420634 — Multilevel Ecological and COM-B Determinants of Medication Adherence in Adults With Diabetes · recruiting
NCT07114822 — HOPE Intervention for Fitness · NA · recruiting
NCT07245082 — Patients With Type 2 Diabetes · recruiting
NCT07065383 — Rebalancing the Fat Content of the Heart and Muscles · NA · recruiting

Other University of Split, School of Medicine trials

Trials by the same sponsor.

NCT07286487 — Glycyrrhetinic Acid and Acute Irritant Dermatitis · NA · not yet recruiting
NCT07314944 — Maternal Sleep and Lifestyle, Metabolic Health, and Perinatal Outcomes in Gestational Diabetes · recruiting
NCT07140107 — Effectiveness of Original vs. AI-Generated Plain Language Summaries of Systematic Reviews · NA · enrolling by invitation
NCT07078474 — Comparison of Skin Condition After Hyaluronic Acid Application on Dry vs. Moist Skin · NA · completed
NCT07079371 — Micellar Water and the Skin Barrier: Comparing Rinsing vs. Non-Rinsing Application · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07017127 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Split, School of Medicine
Last refreshed: 12 June 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07017127.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing